The EML4-ALK fusion gene was first described in 2007 by Soda and colleagues [2], who screened a cDNA library derived from the cancer tissue of a 62-year-old Japanese male patient with NSCLC. This evidence concerns the gene ALK and non-small cell lung carcinoma.